Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

The nutritional status in CF: Being certain about the uncertainties.

Declercq D, Van Meerhaeghe S, Marchand S, Van Braeckel E, van Daele S, De Baets F, Van Biervliet S.

Clin Nutr ESPEN. 2019 Feb;29:15-21. doi: 10.1016/j.clnesp.2018.10.009. Epub 2018 Nov 7. Review.

PMID:
30661680
2.

A CARD9 Founder Mutation Disrupts NF-κB Signaling by Inhibiting BCL10 and MALT1 Recruitment and Signalosome Formation.

De Bruyne M, Hoste L, Bogaert DJ, Van den Bossche L, Tavernier SJ, Parthoens E, Migaud M, Konopnicki D, Yombi JC, Lambrecht BN, van Daele S, Alves de Medeiros AK, Brochez L, Beyaert R, De Baere E, Puel A, Casanova JL, Goffard JC, Savvides SN, Haerynck F, Staal J, Dullaers M.

Front Immunol. 2018 Oct 31;9:2366. doi: 10.3389/fimmu.2018.02366. eCollection 2018.

3.

Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.

De Baets F, De Keyzer L, Van Daele S, Schelstraete P, Van Biervliet S, Van Braeckel E, Thomas M, Wanyama SS.

Pediatr Allergy Immunol. 2018 Nov;29(7):726-731. doi: 10.1111/pai.12953. Epub 2018 Aug 23.

PMID:
29981532
4.

Establishing the diagnosis of chronic colonization with Pseudomonas aeruginosa of cystic fibrosis patients: Comparison of the European consensus criteria with genotyping of P. aeruginosa isolates.

Jonckheere L, Schelstraete P, Van Simaey L, Van Braeckel E, Willekens J, Van Daele S, De Baets F, Vaneechoutte M.

J Cyst Fibros. 2018 Nov;17(6):729-735. doi: 10.1016/j.jcf.2018.03.004. Epub 2018 Apr 11.

PMID:
29655935
5.

The effect of enteral tube feeding in cystic fibrosis: A registry based study.

Libeert D, Declercq D, Wanyama S, Thomas M, Van Daele S, De Baets F, Van Biervliet S.

J Cyst Fibros. 2018 Mar;17(2):264-270. doi: 10.1016/j.jcf.2018.01.004. Epub 2018 Feb 1.

PMID:
29396026
6.

Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patients.

Forier K, Van Heck V, Carlier M, Van Braeckel E, Van Daele S, De Baets F, Schelstraete P, Haerynck F, Stove V, Van Simaey L, Vaneechoutte M, Verstraete AG.

J Antimicrob Chemother. 2018 Jan 1;73(1):95-101. doi: 10.1093/jac/dkx331.

PMID:
29029070
7.

Exercise performance and quality of life in children with cystic fibrosis and mildly impaired lung function: relation with antibiotic treatments and hospitalization.

Vandekerckhove K, Keyzer M, Cornette J, Coomans I, Pyl F, De Baets F, Schelstraete P, Haerynck F, De Wolf D, Van Daele S, Boone J.

Eur J Pediatr. 2017 Dec;176(12):1689-1696. doi: 10.1007/s00431-017-3024-7. Epub 2017 Sep 30.

PMID:
28965267
8.

When One Rare Disease Hides Another: Kartagener Syndrome Masking FMF.

Hoste L, De Baets F, Van Daele S, Schelstraete P, Boon M, De Bruyne M, Dullaers M, Coppieters F, Haerynck F.

Clin Pediatr (Phila). 2018 Jul;57(8):981-985. doi: 10.1177/0009922817733705. Epub 2017 Sep 27. No abstract available.

PMID:
28952366
9.

Gastro-intestinal manifestations in cystic fibrosis patients.

Van Biervliet S, de Clercq C, Declercq D, Van Braeckel E, Van Daele S, De Baets F, De Looze D.

Acta Gastroenterol Belg. 2016 Sep-Dec;79(4):481-486. Review.

PMID:
28209107
10.

Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.

Nguyen LD, Deschaght P, Merlin S, Loywick A, Audebert C, Van Daele S, Viscogliosi E, Vaneechoutte M, Delhaes L.

PLoS One. 2016 Dec 28;11(12):e0168860. doi: 10.1371/journal.pone.0168860. eCollection 2016.

11.

Recurrent spontaneous pneumomediastinum in a child with tracheomalacia.

Dewulf J, Van Daele S, De Baets F.

Pediatr Pulmonol. 2017 Jun;52(6):E29-E31. doi: 10.1002/ppul.23624. Epub 2016 Oct 10.

PMID:
27723958
12.

Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.

Cools P, Ho E, Vranckx K, Schelstraete P, Wurth B, Franckx H, Ieven G, Van Simaey L, Van Daele S, Verhulst S, De Baets F, Vaneechoutte M.

BMC Microbiol. 2016 Jun 24;16(1):122. doi: 10.1186/s12866-016-0736-1. Review.

13.

Erratum to: Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency.

de Medeiros AK, Lodewick E, Bogaert DJ, Haerynck F, Van Daele S, Lambrecht B, Bosma S, Vanderdonckt L, Lortholary O, Migaud M, Casanova JL, Puel A, Lanternier F, Lambert J, Brochez L, Dullaers M.

J Clin Immunol. 2016 Jul;36(5):528. No abstract available.

PMID:
27116191
14.

Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency.

Alves de Medeiros AK, Lodewick E, Bogaert DJ, Haerynck F, Van Daele S, Lambrecht B, Bosma S, Vanderdonckt L, Lortholary O, Migaud M, Casanova JL, Puel A, Lanternier F, Lambert J, Brochez L, Dullaers M.

J Clin Immunol. 2016 Apr;36(3):204-9. doi: 10.1007/s10875-016-0255-8. Epub 2016 Mar 9. Erratum in: J Clin Immunol. 2016 Jul;36(5):528.

PMID:
26961233
15.

Communication in healthcare: a narrative review of the literature and practical recommendations.

Vermeir P, Vandijck D, Degroote S, Peleman R, Verhaeghe R, Mortier E, Hallaert G, Van Daele S, Buylaert W, Vogelaers D.

Int J Clin Pract. 2015 Nov;69(11):1257-67. doi: 10.1111/ijcp.12686. Epub 2015 Jul 6. Review.

16.

Colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis patients.

Claus BO, Snauwaert S, Haerynck F, Van Daele S, De Baets F, Schelstraete P.

Int J Clin Pharm. 2015 Aug;37(4):555-8. doi: 10.1007/s11096-015-0077-4. Epub 2015 May 23.

PMID:
26001357
17.

Quantitative bone ultrasound at the distal radius in adults with cystic fibrosis.

Roggen I, Louis O, Van Biervliet S, Van Daele S, Robberecht E, De Wachter E, Malfroot A, De Waele K, Gies I, Vanbesien J, De Schepper J.

Ultrasound Med Biol. 2015 Jan;41(1):334-8. doi: 10.1016/j.ultrasmedbio.2014.08.003. Epub 2014 Oct 22.

PMID:
25438860
18.

Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis.

Hildebrandt J, Yalcin E, Bresser HG, Cinel G, Gappa M, Haghighi A, Kiper N, Khalilzadeh S, Reiter K, Sayer J, Schwerk N, Sibbersen A, Van Daele S, Nübling G, Lohse P, Griese M.

Orphanet J Rare Dis. 2014 Nov 26;9:171. doi: 10.1186/s13023-014-0171-z.

19.

MCIDAS mutations result in a mucociliary clearance disorder with reduced generation of multiple motile cilia.

Boon M, Wallmeier J, Ma L, Loges NT, Jaspers M, Olbrich H, Dougherty GW, Raidt J, Werner C, Amirav I, Hevroni A, Abitbul R, Avital A, Soferman R, Wessels M, O'Callaghan C, Chung EM, Rutman A, Hirst RA, Moya E, Mitchison HM, Van Daele S, De Boeck K, Jorissen M, Kintner C, Cuppens H, Omran H.

Nat Commun. 2014 Jul 22;5:4418. doi: 10.1038/ncomms5418.

PMID:
25048963
20.

Primary ciliary dyskinesia: critical evaluation of clinical symptoms and diagnosis in patients with normal and abnormal ultrastructure.

Boon M, Smits A, Cuppens H, Jaspers M, Proesmans M, Dupont LJ, Vermeulen FL, Van Daele S, Malfroot A, Godding V, Jorissen M, De Boeck K.

Orphanet J Rare Dis. 2014 Jan 22;9:11. doi: 10.1186/1750-1172-9-11.

21.

Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load?

Deschaght P, Schelstraete P, Van Simaey L, Vanderkercken M, Raman A, Mahieu L, Van Daele S, De Baets F, Vaneechoutte M.

PLoS One. 2013 Nov 29;8(11):e79010. doi: 10.1371/journal.pone.0079010. eCollection 2013.

22.

Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis.

De Baets F, Schelstraete P, Haerynck F, Van Biervliet S, De Bruyne R, Franckx H, Van Daele S.

Pediatr Pulmonol. 2014 Apr;49(4):414-6. doi: 10.1002/ppul.22864. Epub 2013 Aug 23.

PMID:
24039244
23.

Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.

Haerynck F, Mahachie John JM, Van Steen K, Schelstraete P, Van daele S, Loeys B, Van Thielen M, De Canck I, Nuytinck L, De Baets F.

Hum Immunol. 2013 Dec;74(12):1649-55. doi: 10.1016/j.humimm.2013.08.282. Epub 2013 Aug 29.

PMID:
23994582
24.

Randomized trial of modified constraint-induced movement therapy with and without an intensive therapy program in children with unilateral cerebral palsy.

Klingels K, Feys H, Molenaers G, Verbeke G, Van Daele S, Hoskens J, Desloovere K, De Cock P.

Neurorehabil Neural Repair. 2013 Nov-Dec;27(9):799-807. doi: 10.1177/1545968313496322. Epub 2013 Jul 30.

PMID:
23901061
25.

Polymorphisms in the lectin pathway genes as a possible cause of early chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients.

Haerynck F, Van Steen K, Cattaert T, Loeys B, Van Daele S, Schelstraete P, Claes K, Van Thielen M, De Canck I, Mahachie John JM, De Baets F.

Hum Immunol. 2012 Nov;73(11):1175-83. doi: 10.1016/j.humimm.2012.08.010. Epub 2012 Aug 29.

PMID:
22940091
26.

Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa.

Schelstraete P, Haerynck F, Van daele S, Deseyne S, De Baets F.

J Cyst Fibros. 2013 Jan;12(1):1-8. doi: 10.1016/j.jcf.2012.07.008. Epub 2012 Aug 29. Review.

27.

Malacia, inflammation and bronchoalveolar lavage culture in children with persistent respiratory symptoms.

De Baets F, De Schutter I, Aarts C, Haerynck F, Van Daele S, De Wachter E, Malfroot A, Schelstraete P.

Eur Respir J. 2012 Feb;39(2):392-5. doi: 10.1183/09031936.00035111. Epub 2011 Jul 20.

28.

PCR and the detection of Pseudomonas aeruginosa in respiratory samples of CF patients. A literature review.

Deschaght P, Van Daele S, De Baets F, Vaneechoutte M.

J Cyst Fibros. 2011 Sep;10(5):293-7. doi: 10.1016/j.jcf.2011.05.004. Review.

29.

Neonatal pulmonary interstitial glycogenosis in a patient with Hunter syndrome.

Smets K, Van Daele S.

Eur J Pediatr. 2011 Aug;170(8):1083-4. doi: 10.1007/s00431-011-1444-3. Epub 2011 Mar 22. No abstract available.

PMID:
21424671
30.

Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients.

Deschaght P, Schelstraete P, Lopes dos Santos Santiago G, Van Simaey L, Haerynck F, Van Daele S, De Wachter E, Malfroot A, Lebecque P, Knoop C, Casimir G, Boboli H, Pierart F, Desager K, Vaneechoutte M, De Baets F.

BMC Microbiol. 2010 Sep 24;10:245. doi: 10.1186/1471-2180-10-245.

31.

Milk protein and Oil-Red-O staining of alveolar macrophages in chronic respiratory disease of infancy.

De Baets F, Aarts C, Van Daele S, Haerynck F, De Wachter E, De Schutter I, Malfroot A, Schelstraete P.

Pediatr Pulmonol. 2010 Dec;45(12):1213-9. doi: 10.1002/ppul.21310. Epub 2010 Aug 17.

PMID:
20717909
32.

Security risks in nuclear waste management: Exceptionalism, opaqueness and vulnerability.

Vander Beken T, Dorn N, Van Daele S.

J Environ Manage. 2010 Mar-Apr;91(4):940-8. doi: 10.1016/j.jenvman.2009.11.012. Epub 2009 Dec 21.

PMID:
20022419
33.

Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients.

Schelstraete P, Deschaght P, Van Simaey L, Van Daele S, Haerynck F, Vaneechoutte M, De Baets F.

J Cyst Fibros. 2010 Mar;9(2):99-103. doi: 10.1016/j.jcf.2009.11.006. Epub 2009 Dec 8.

34.

Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients.

Deschaght P, De Baere T, Van Simaey L, Van Daele S, De Baets F, De Vos D, Pirnay JP, Vaneechoutte M.

BMC Microbiol. 2009 Nov 29;9:244. doi: 10.1186/1471-2180-9-244.

35.

Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients.

Schelstraete P, Van Daele S, De Boeck K, Proesmans M, Lebecque P, Leclercq-Foucart J, Malfroot A, Vaneechoutte M, De Baets F.

Eur Respir J. 2008 Apr;31(4):822-9. Epub 2007 Dec 19.

36.

Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.

De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M.

J Cyst Fibros. 2007 Jan;6(1):75-8. Epub 2006 Jun 21.

37.

Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients.

Van Daele S, Vaneechoutte M, De Boeck K, Knoop C, Malfroot A, Lebecque P, Leclercq-Foucart J, Van Schil L, Desager K, De Baets F.

Eur Respir J. 2006 Oct;28(4):740-7. Epub 2006 Jun 14.

38.

Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.

Van Daele S, Verhelst R, Claeys G, Verschraegen G, Franckx H, Van Simaey L, de Ganck C, De Baets F, Vaneechoutte M.

J Clin Microbiol. 2005 Jun;43(6):2998-3002.

39.

Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre.

Van Daele SG, Franckx H, Verhelst R, Schelstraete P, Haerynck F, Van Simaey L, Claeys G, Vaneechoutte M, de Baets F.

Eur Respir J. 2005 Mar;25(3):474-81.

40.

Exercise-induced respiratory symptoms are poor predictors of bronchoconstriction.

De Baets F, Bodart E, Dramaix-Wilmet M, Van Daele S, de Bilderling G, Masset S, Vermeire P, Michel O.

Pediatr Pulmonol. 2005 Apr;39(4):301-5.

PMID:
15678500
41.

Asphyxiating tracheal bronchogenic cyst.

De Baets F, Van Daele S, Schelstraete P, Haerynck F, Vermassen F, Broers C.

Pediatr Pulmonol. 2004 Dec;38(6):488-90.

PMID:
15514990
42.

Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?

Jacquy C, Lambert F, Soree A, Van Daele S, Heusterspreute M, Bosly A, Ferrant A, Parma J, Bron D, Martiat P.

Bone Marrow Transplant. 1999 Apr;23(7):681-6.

43.

Inhaled steroids compared with disodium cromoglycate in preschool children with episodic viral wheeze.

De Baets F, Van Daele S, Franckx H, Vinaimont F.

Pediatr Pulmonol. 1998 Jun;25(6):361-6.

PMID:
9671161
44.

A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse.

Jacquy C, Delepaut B, Van Daele S, Vaerman JL, Zenebergh A, Brichard B, Vermylen C, Cornu G, Martiat P.

Br J Haematol. 1997 Jul;98(1):140-6.

PMID:
9233577
45.

Fibrotic eye muscles, Axenfeld anomaly, flat face, and mild developmental retardation: a new example of the Chitty syndrome.

Van Daele SG, Van Coster RN, Meire F, Smets AM, Leroy JG.

Am J Med Genet. 1996 Oct 28;65(3):205-8.

PMID:
9240744
46.

A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission.

Filleul B, Delannoy A, Ferrant A, Zenebergh A, Van Daele S, Bosly A, Doyen C, Mineur P, Glorieux P, Driesschaert P, et al.

Leukemia. 1994 Jul;8(7):1153-6.

PMID:
7913513
47.

Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction.

Nizet Y, Van Daele S, Lewalle P, Vaerman JL, Philippe M, Vermylen C, Cornu G, Ferrant A, Michaux JL, Martiat P.

Blood. 1993 Sep 1;82(5):1618-25.

48.
49.

The subcellular localization of the neu protein in human normal and neoplastic cells.

De Potter CR, Quatacker J, Maertens G, Van Daele S, Pauwels C, Verhofstede C, Eechaute W, Roels H.

Int J Cancer. 1989 Dec 15;44(6):969-74.

PMID:
2575084
50.

The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues.

De Potter CR, Van Daele S, Van de Vijver MJ, Pauwels C, Maertens G, De Boever J, Vandekerckhove D, Roels H.

Histopathology. 1989 Oct;15(4):351-62.

PMID:
2572531

Supplemental Content

Loading ...
Support Center